SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-016628
Filing Date
2022-11-07
Accepted
2022-11-07 16:20:43
Documents
65
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q agrx-20220930x10q.htm   iXBRL 10-Q 1525703
2 EX-10.1 agrx-20220930xex10d1.htm EX-10.1 37446
3 EX-10.2 agrx-20220930xex10d2.htm EX-10.2 85376
4 EX-31.1 agrx-20220930xex31d1.htm EX-31.1 10623
5 EX-31.2 agrx-20220930xex31d2.htm EX-31.2 10551
6 EX-32.1 agrx-20220930xex32d1.htm EX-32.1 5942
7 EX-32.2 agrx-20220930xex32d2.htm EX-32.2 5895
  Complete submission text file 0001558370-22-016628.txt   6126131

Data Files

Seq Description Document Type Size
8 EX-101.SCH agrx-20220930.xsd EX-101.SCH 45678
9 EX-101.CAL agrx-20220930_cal.xml EX-101.CAL 44640
10 EX-101.DEF agrx-20220930_def.xml EX-101.DEF 179270
11 EX-101.LAB agrx-20220930_lab.xml EX-101.LAB 402399
12 EX-101.PRE agrx-20220930_pre.xml EX-101.PRE 288809
59 EXTRACTED XBRL INSTANCE DOCUMENT agrx-20220930x10q_htm.xml XML 834144
Mailing Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635
Business Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635 609-683-1880
AGILE THERAPEUTICS INC (Filer) CIK: 0001261249 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36464 | Film No.: 221365754
SIC: 2834 Pharmaceutical Preparations